Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

BEAM vs DNLI: stock comparison and AI forecast

Beam Therapeutics Inc. (BEAM) and Denali Therapeutics Inc. (DNLI) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Biological Products, (No Diagnostic Substances)

BEAM Beam Therapeutics Inc.

Price
$25.87 -14.0% · 6M
Market Cap
$2.72B
P/E Ratio
376.1x
Size
mid-cap
AI Forecast
Full analysis →
Nasdaq · Biological Products, (No Diagnostic Substances)

DNLI Denali Therapeutics Inc.

Market Cap
$3.03B
P/E Ratio
–
Size
mid-cap
AI Forecast
NO CURRENT FORECAST
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

BEAM · DNLI

Key facts

  • DNLI is 1.1 times larger than BEAM by market capitalization ($3.03B against $2.72B).
  • DNLI carries 0.39 times debt per unit of equity, against 0.33 times for BEAM.
  • Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricBEAMDNLI
Market Cap$2.72B$3.03B
P/E Ratio376.13x–
P/B Ratio2.85x3.62x
EPS$0.07$-2.93
Book Value/Share$9.22$5.22
Revenue/Share$1.42–
FCF/Share$-3.86$-2.74

Profitability & Margins

MetricBEAMDNLI
ROE–-61.2%
ROA–-44.2%
ROIC-33.1%-50.8%
Operating Margin-267.7%-15058.2%
Net Margin–-14191.2%
EBT Margin-89.2%-15058.2%
Tax Rate0.0%-0.0%

Financial Health

MetricBEAMDNLI
Current Ratio13.00x8.37x
Quick Ratio–8.32x
D/E Ratio0.33x0.39x
Financial Leverage1.33x1.39x
Interest Coverage-54.5x–
Working Capital$985M$664M

Cash Flow

MetricBEAMDNLI
Operating Cash Flow-$389M-$434M
Free Cash Flow-$398M-$437M
Capital Spending-$10M-$3M
FCF/Sales-271.6%–
CapEx/Sales6.5%–

Operational Efficiency

MetricBEAMDNLI
Asset Turnover0.12x–
Fixed Assets Turnover1.6x–

Income Statement

MetricBEAMDNLI
Total Revenue$147M–
Operating Income-$393M-$543M
Net Income–-$511M
R&D Expense$409M$401M

Dividend & Shareholder Information

MetricBEAMDNLI
Shares Outstanding103M160M
FAQ

BEAM vs DNLI: stock comparison and AI forecast

Which is bigger, BEAM or DNLI?

DNLI is 1.1 times larger than BEAM by market capitalization ($3.03B against $2.72B).

Which one does Intratio's AI model rank higher, BEAM or DNLI?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.